Table 2.
C | DNP- | DNP+ | |
---|---|---|---|
RBF baseline (arbitrary units) | 162 ± 29 | 159 ± 42 | 217 ± 112* ,$ |
RBF stimulated (arbitrary units) | 173 ± 30 | 164 ± 36 | 232 ± 101* ,$ |
Delta RBF after flicker (%) | 10.2 ± 10.9 | 10.4 ± 14.9 | 14.0 ± 13.1 |
WLR | 0.42 ± 0.07 | 0.46 ± 0.09 | 0.43 ± 0.09 |
NDS | 0.6 ± 1.2 | 0.4 ± 0.9 | 3.8 ± 1.2* ,$ |
VPT | 4.6 ± 3.0 | 6.5 ± 7.0 | 11.4 ± 11.7* ,$ |
Values are mean ± SD. C, control; DNP-, type 1 diabetic patients without neuropathy; DNP+, type 1 diabetic patients with neuropathy.
P < .05 vs control group. $ P < .05 vs DNP-.